EUnetHTA and the EU Joint HTA Process EUnetHTA was established in 2006 to facilitate information sha...
Read moreIntroduction Achieving access to patients for innovative treatments is becoming a significant challe...
Read moreThe aim of this trial is to increase capacity, with a goal of a 20% increase by 2023-24.
Read moreEUnetHTA and the EU Joint HTA Process Originally set up in 2006, EUnetHTA was established to facilit...
Read moreThe drug was judged to offer an indication of major additional benefit in adult patients with advanc...
Read moreIntroduction For some manufacturers, launching in the Middle East and North Africa (MENA) is fraught...
Read moreWith respects to pricing and reimbursement, the societies reportedly call for the criteria that led ...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreIntroduction Health Technology Assessment (HTA) implementation has been historically slow in Asia co...
Read moreA short, 60 seconds read that summarises 4 handpicked articles that are worth reading about: Regulat...
Read more